New mutations inactivating transferrin receptor 2 in hemochromatosis type 3.

Blood
Antonella RoettoC Camaschella

Abstract

Hereditary hemochromatosis usually results from C282Y homozygosity in the HFE gene on chromosome 6p. Recently, a new type of hemochromatosis (HFE3) has been characterized in 2 unrelated Italian families with a disorder linked to 7q. Patients with HFE3 have transferrin receptor 2 (TFR2) inactivated by a homozygous nonsense mutation (Y250X). Here the identification of 2 new TFR2 mutations is reported. In a large inbred family from Campania, a frameshift mutation (84-88 insC) in exon 2 that causes a premature stop codon (E60X) is identified. In a single patient with nonfamilial hemochromatosis, a T-->A transversion (T515A), which causes a Methionine-->Lysine substitution at position 172 of the protein (M172K), has been characterized. TFR2 gene gives origin to 2 alternatively spliced transcripts-the alpha-transcript, which may encode a transmembrane protein, and the beta-transcript, a shorter, possibly intracellular variant. Based on their positions, the effects of the identified mutations on the 2 TFR2 forms are expected to differ. Y250X inactivates both transcripts, whereas E60X inactivates only the alpha-form. M172K has a complex effect: it causes a missense in the alpha-form, but it may also prevent the beta-form production bec...Continue Reading

References

Jan 1, 1996·Blood Cells, Molecules & Diseases·E BeutlerM Chorney
Jul 15, 1997·Annals of Internal Medicine·R MoirandY Deugnier
May 30, 1998·Gastroenterology·A PipernoC Camaschella
Jun 17, 1998·Journal of Internal Medicine·E M CardosoR Hultcrantz
Aug 8, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N J ShaheenI S Grimm
Dec 16, 1998·Blood Cells, Molecules & Diseases·E RyanJ Crowe
Apr 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C CamaschellaA Piperno
Jul 20, 1999·The Journal of Biological Chemistry·H KawabataH P Koeffler
Sep 2, 1999·Human Molecular Genetics·P A Frischmeyer, H C Dietz
Feb 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·R E FlemingW S Sly
May 3, 2000·The Journal of Clinical Investigation·J E LevyN C Andrews
May 10, 2000·Nature Genetics·C CamaschellaP Gasparini

❮ Previous
Next ❯

Citations

Nov 6, 2002·International Journal of Hematology·Yutaka KohgoJunji Kato
Dec 13, 2006·Journal of Molecular Evolution·Lisa Ann Lambert, Stacey L Mitchell
Feb 11, 2005·Current Gastroenterology Reports·James E Nelson, Kris V Kowdley
Dec 22, 2006·Current Treatment Options in Gastroenterology·Narendra Siddaiah, Kris V Kowdley
Mar 2, 2005·Best Practice & Research. Clinical Haematology·Antonella Roetto, Clara Camaschella
Nov 30, 2002·Lancet·Adrian Bomford
Feb 20, 2003·Journal of Hepatology·Stephen A Harrison, Bruce R Bacon
Jul 23, 2003·Journal of Hepatology·Anne-Marie JouanollePierre Brissot
May 10, 2003·Blood Cells, Molecules & Diseases·David M Frazer, Gregory J Anderson
Jan 18, 2003·The International Journal of Biochemistry & Cell Biology·Debbie Trinder, Erica Baker
Dec 7, 2002·Nature Genetics·Antonella RoettoClara Camaschella
Sep 1, 2005·European Journal of Human Genetics : EJHG·Gérald Le Gac, Claude Férec
Apr 22, 2009·Molecular BioSystems·Valerie HowerSuzy V Torti
Nov 28, 2002·Alimentary Pharmacology & Therapeutics·C A Whittington, K V Kowdley
Sep 1, 2001·British Journal of Haematology·H A JacksonM Worwood
Jun 13, 2002·British Journal of Haematology·Marco De GobbiClara Camaschella
Oct 17, 2002·Seminars in Hematology·Clara CamaschellaMarco De Gobbi
Oct 17, 2002·Seminars in Hematology·Prem Ponka
Nov 30, 2005·Seminars in Liver Disease·Robert E FlemingBruce R Bacon
Jan 27, 2012·The New England Journal of Medicine·Robert E Fleming, Prem Ponka
Apr 9, 2004·The Proceedings of the Nutrition Society·Johanne McGregorRobert J Simpson
Oct 24, 2007·Genetic Testing·James C BartonUNKNOWN Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators
Feb 24, 2005·Current Opinion in Hematology·Cindy N Roy, Nancy C Andrews
Feb 16, 2005·Current Opinion in Gastroenterology·Robert E Fleming
Apr 20, 2005·Journal of Gastroenterology and Hepatology·Masaki TakeoYukihiko Adachi
Oct 7, 2004·Journal of Medical Genetics·K J H RobsonJ Rochette
Nov 21, 2002·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Tapasree GoswamiMatthias A Hediger
Jan 18, 2006·Annual Review of Medicine·Ernest Beutler
Jul 20, 2006·Annual Review of Nutrition·Antonello Pietrangelo
Apr 30, 2009·Annual Review of Pathology·Pauline L Lee, Ernest Beutler
Feb 5, 2002·Annual Review of Physiology·Robert E Fleming, William S Sly
Aug 24, 2001·The Journal of Clinical Investigation·G MontosiA Pietrangelo
Apr 6, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Francesco De MarcoVincenzo De Simone
Nov 16, 2006·Internal Medicine·Hisao HayashiTakaaki Ikeda
Feb 6, 2009·World Journal of Gastroenterology : WJG·Alberto PipernoDomenico Girelli
Jul 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·R E Fleming, W S Sly
Sep 24, 2013·Blood Cells, Molecules & Diseases·Francesca Clementina RadioPaola Grammatico
Dec 11, 2013·Clinics and Research in Hepatology and Gastroenterology·Edouard Bardou-JacquetPierre Brissot
Jul 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·Robert E FlemingWilliam S Sly
Jan 25, 2003·Tissue Antigens·D C JonesM Bunce
Apr 12, 2011·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Mark R Bleackley, Ross T A Macgillivray
Jun 14, 2012·Clinical & Developmental Immunology·Greg S Gojanovich, Paul R Hess

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.